Menlo Ventures Announces Cohort Backed by the $100M Anthology Fund Launched in Partnership with Anthropic
December 18, 2024 11:00 ET
|
Menlo Ventures
MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Menlo Ventures, a leading venture capital firm investing at the forefront of AI, announced its first cohort of 18 companies backed by the $100...
FE International Expands Fundraising Services with Funden Partnership
December 17, 2024 09:00 ET
|
FE International
FE International partners with Funden to connect early-stage founders to 1,100+ VCs, offering M&A expertise and fundraising support to drive growth.
YL Ventures Identifies key Cybersecurity Sectors set to Dominate in 2025
December 10, 2024 13:10 ET
|
YL Ventures
SAN FRANCISCO and TEL AVIV, Israel, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Global cybersecurity venture capital firm, YL Ventures, today released its predictions for the most promising cybersecurity...
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
November 21, 2024 09:00 ET
|
DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform.
Menlo Ventures’ 2024 State of Generative AI Report Reveals 6x Spike in Enterprise Spending as Market Leaders Shift
November 20, 2024 14:30 ET
|
Menlo Ventures
MENLO PARK, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Menlo Ventures, a leading venture capital firm investing at the forefront of AI, released its second annual State of Generative AI in the...
4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED
November 14, 2024 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED
November 14, 2024 03:00 ET
|
4Bio Capital
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
11x Raises a $50 Million Series B Led by Andreessen Horowitz to Accelerate the Era of Digital Workers
November 11, 2024 12:00 ET
|
11X AI INC.
SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by...